---
title: "Why IL13Rα2 Matters"
date: "2025-04-01"
author: "Myron Schram"
tags: [science, protocol, CAR-T]
---

IL13Rα2 is a promising target in pediatric brain cancer treatment.

Unlike other receptors, it’s overexpressed in tumors and rarely found in healthy tissue. This makes it ideal for precision CAR T-cell therapy.

We're leveraging this breakthrough to build a protocol that gives kids a chance.
![Hunter on the ranch](/hunter.jpg)

